Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 82.35

-4.5%

Jan 8 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2112)	2/27/2008 1:25:01 PM
From: Jibacoa	Read Replies (2) of 3722

VPHM Is holding above yesterday's close after reporting today its 4thQ results in which it said it had better sales of Vancocin; it received Orphan Drug Designation for its Camvia in Europe;( Camvia is on PIIIs in stem in cell and solid organ transplant patients & VPHM plans to submit NDA & MAA filings in 2009) The stock is up 1.41%.Volume of 926,973 is still below its ADV bigcharts.marketwatch.com The stock is trading around 1.6xBV The short ratio is around 9x its ADV The "analysts" have a target around $12.88 The stock remains on the longer term DT coming from the Nov 2005 at $24.36 Its March 2000 H was $111.62 bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next